Another study in CRC showed that blocking the CSF-1R with PLX3397 in multiple murine models reduces M2-like TAM infiltration and enhances CD8+ T cell infiltration, validating again the role of this receptor in shaping the immune landscape of the TME [50], and the same was demonstrated in very recent studies [51,52]. The gene discussed is CD8A; the disease is colorectal carcinoma.